Three vaccination regimes based on Clostridium perfringens (C. perfringens) type A, C or combined AC toxoids were evaluated to detect if toxoid vaccines can prevent necrtotic enteritis (NE) caused by clostridial infection in broilers. The vaccines were administered two times at two weeks interval, then the birds were challenged with virulent strains of C. perfringens type A, C or combined AC. Blood samples were taken after both first and second vaccination doses as well as after challenge. Evaluating parameters included clinical signs, gross intestinal lesions, hemogram [red blood cell count (RBCs), packed cell volume (PCV), hemoglobin (Hb), total leukocytic count (TLC) and differential leukocytic count],serum biochemical assays [total protein (TP), albumin (Alb), globulin (Glob), albumin globulin ratio (A/G), serum activities of alanine amino transferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP) and uric acid (UA) values] and ELISA test for detecting serum antibody titers. Results revealed that affected birds showed marked depression, anorexia, reluctance to move, ruffled feathers and diarrhea. Numbers of chickens with intestinal lesions in immunized challenged groups were greatly fewer than the infected non immunized ones. There was an increase in RBCs, PCV and Hb. TLC decreased in infected non immunized birds and increased in vaccinated ones. Heterophils were increased in infected groups while, lymphocytes decreased. Prominent lymphocytosis was observed in immunized birds. Results of biochemical assays showed that there was a significant increase in TP, Alb, Glob, ALP, ALT, AST and UA and decrease in A/G. Results of ELISA test showed that there was a significant increase in antibody titer after immunization paricularly after the second dose of vaccination. The combined AC toxoid provided the greater antibody titer and best protection followed by toxoid A and finally toxoid C. We concluded that results provide an evidence that immunization of broilers with toxoid vaccines paricularly the combined type AC is safe, welltolerated and can protect broiler chickens against NE after the second booster dose of the vaccine.

The present study concerned with Listeria monocytogenes which were isolated from apparently healthy buffaloes, buffaloes suffered from abortion, bedding and silage, which were collected from different localities. From the total examined samples (375), (300 samples from apparently healthy buffaloes, bedding and silage, also 75 samples from buffaloes suffered from abortion , bedding and silage) the prevalence of L. monocytogenes was 11(14.7%), isolates from buffaloes suffered from abortion, bedding and silage. All isolates were motile at room temperature, also exhibited positive CAMP test and exhibited narrow zone of β-hemolysis. Serological identification of isolates revealed 6(54.5%) were serotype 4 while 5(45.5%) were untyped. There were differences in isolates susceptibilities to different anti-microbial agents. L. monocytogenes had 100% sensitivity to Ampicillin, chloramphenicol, erythromycin, tetracycline and ceftiofur sodium. Virulence of isolates was assayed by I/P inoculation of 109 CFU in mice, all inoculated mice died within 1-5 days. PCR assay for L. monocytogenes isolates revealed positive amplification of 827 bp fragment of act A gene.

In the conditions of the Republic of Belarus by an example model of a purulent wound at rats there was realized an experimental study of pharmacological activity of a medical remedy PhytoMP (containing active substances of Macleaya microcarpa (Maxim.) Fedde of Papaveraceae family; and Plantago major L. of Plantaginaceae family) in the form of powder. It was established, that the intensity wound-healthing effect depended on a ratio of the components plume poppy / greater plantain 1 + 1:1, 2:1, 1:2. Studying of the remedy safety showed that PhytoMP in the maximal dozes was not toxic for animals after a single unitary intragastric administration in dose of 50000 mg/kg to mice and in dose of 20833 mg/kg to rats. The mentioned above indexes surpassed the recommended for human dose after application tonsilles (1,428 mg/kg) in 35014 and 14589 times, and also the recommended for human doses for application at a wound with size of 2x2 square cm (11,424 mg/kg) - in 4377 and 1824 times, respectively.